Progyny
Insurance · New York, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
1359 Broadway Fl 2, New York City, New Y...Phone Number
(888) 597-5065Website
www.progyny.comRevenue
$1.3 BillionStock Symbol
PGNYIndustry
ZI Rank: 9
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
10
9
8
11
13
9
About Progyny
Progyny is a leading fertility benefits management company in the United States. Founded in 2008 and headquartered in New York City, the company specializes in providing comprehensive fertility and family building benefit solutions. Progyny offers a unique benefits platform that connects patients with fertility specialists and advanced reproductive technologies while managing costs for employers. The company's services include patient education, dedicated advocacy support, and access to a premier network of fertility specialists. Progyny's approach aims to improve clinical outcomes while making fertility treatments more accessible and cost-effective. The company operates with a vision of expanding fertility care access to anyone wanting to build a family, offering both mobile app support and B2B services within the insurance industry.Explore more
Progyny Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Progyny your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Progyny has new funding data
Check out if Progyny is spiking on competitors!
Progyny, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Progyny recently announced quarterly report
Check if Progyny has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Progyny launches new products
Click to see if Progyny had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Progyny
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Progyny
Find 3 more new buyers
Compare Similar Companies to Progyny
Compare insights from companies similar to Progyny, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Compare CEO
How does Peter Anevski compare against Competing Companies' CEOs?
PA
Peter Anevski
Chief Executive Officer at Progyny
Top 20%
CEO effectiveness to drive business results
Excellent
0%
Good
100%
Average
0%
Poor
0%
Very Bad
0%
Good
50%Bad
50%VS.
PB
Piraye Beim
CEO at Celmatix
Top 40%
CEO effectiveness to drive business results
Excellent
0%
Good
100%
Average
0%
Poor
0%
Very Bad
0%
Good
100%Bad
0%
Company Profile Activity
Activity Insights
Progyny is experiencing very low activity levels compared to other companies in the Insurance sector.
What does this means?
Progyny is drawing exceptional interest within the Insurance industry, suggesting notable developments or strong market momentum, learn more about Progyny.
Progyny financials insights
Gather financial insights about Progyny, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2012
Series A
$20M
2016
Series B
$14.7M
2017
Other Financing Round
$10M
2019
Stock Offering
$87.1M
Progyny Tech Stack
A closer look at the technologies used by Progyny
See more technologies
Most Recent Scoops
Person-Based
Compensation & Benefits, HR Operations
Person-Based
Earnings, Sales, Finance
Person-Based
Earnings, Finance
Open Position
Open Position
Progyny News & Media
New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System
Patients increasingly say human connection and advocacy are essential to reducing stress and improving the care experience Patients increasingly say human connection and advocacy are essential to reducing stress and improving the care experienceProgyny, Inc. Announces Share Repurchase Program
NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that its Board of Directors has approved a share repurchase program to repurchase up to $200 million of its common stock. The program will be funded through available cash balances.Progyny, Inc. (PGNY) Shareholder/Analyst Call Transcript
Progyny, Inc. (PGNY) Shareholder/Analyst Call May 21, 2026 3:00 PM EDTCompany ParticipantsPeter Anevski - CEO & DirectorAllison Swartz - Executive VP,...Why Is Progyny (PGNY) Stock Soaring Today
Shares of fertility benefits company Progyny (NASDAQ:PGNY) jumped 17.5% in the afternoon session after the company reported first-quarter 2026 financial results that surpassed analyst expectations and raised its full-year guidance.
Read more news
Top Insurance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Progyny
Sign Up For FreeTo access detailed company insights
Progyny is a leading fertility benefits management company in the United States. Founded in 2008 and headquartered in New York City, the company specializes in providing comprehensive fertility and family building benefit solutions. Progyny offers a unique benefits platform that connects patients with fertility specialists and advanced reproductive... Read More
